Tower Research Capital (TRC)’s RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS DRGS Stock Holding History

Tower Research Capital (TRC)’s Portfolio DRGS Stock Details DRGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-104	Closed	-$5K	–	5360
2014 Q3	$5K	Buy	+104	New	+$5.14K	﹤0.01%	3373

Other funds holding DRGS

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Tower Research Capital (TRC)'s DRGS Position: Q4 2014 in Review

Tower Research Capital (TRC) sold out of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) in Q4 2014, closing a stake of 104 shares — an estimated $5K sold.

Tower Research Capital (TRC) first reported a position in DRGS in Q3 2014 and held it in 1 quarter. The position peaked at $5K in Q3 2014. 4 funds tracked by Wall St. Rank hold DRGS as of Q4 2014.

Tower Research Capital (TRC) reported no remaining RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS position as of Q4 2014 after selling out during the quarter.
Tower Research Capital (TRC) sold 104 RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS shares in Q4 2014, an estimated $5K.
Tower Research Capital (TRC) first reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in Q3 2014 and held it in 1 quarter.
Tower Research Capital (TRC)'s RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS position peaked at $5K in Q3 2014.
4 funds tracked by Wall St. Rank held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS as of Q4 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2014, filed 5 Feb 2015.